Regulatory T cell plasticity and immune deviation toward autoinflammation in HTLV-1-associated diseases: insights and implications

Recent evidence suggests that HTLV-1 infection induces the expansion of regulatory T cells (Tregs) with high plasticity, which can convert into effector T cells that promote immune deviation toward autoinflammation, including T-helper1 (Th1) cells, T-helper17 (Th17) cells and a novel effector T helper cell subpopulation with particular specificity for HAM/TSP called T<sub>HAM</sub>s. The development of novel therapeutic strategies targeting these cells paves the way for new therapeutic strategies, which hold significant promise for providing more favorable treatment outcomes for involved individuals and ameliorating patients' symptoms.

Authors

Institutions

Publication Details

Journal
Expert Review of Clinical Immunology
Published
2025-10-03
DOI
https://doi.org/10.1080/1744666x.2025.2575368
Citations
1
Primary Topic
T-cell and Retrovirus Studies
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulatory T cell plasticity and immune deviation toward autoinflammation in HTLV-1-associated diseases: insights and implications

Sayed‐Hamidreza Mozhgani, Atefeh Bahavar, Mohammadreza Shafiei, Vahid Shahnavaz et al.
1 citations
Expert Review of Clinical Immunology
T-cell and Retrovirus Studies
0.80
article

Regulatory T cell plasticity and immune deviation toward autoinflammation in HTLV-1-associated diseases: insights and implications

Sayed‐Hamidreza Mozhgani, Atefeh Bahavar, Mohammadreza Shafiei, Vahid Shahnavaz, Arash Letafati, Mohammad Mahdi Khosravi Nia, Nastaran Ardalan
article en
1 citations

Abstract

Recent evidence suggests that HTLV-1 infection induces the expansion of regulatory T cells (Tregs) with high plasticity, which can convert into effector T cells that promote immune deviation toward autoinflammation, including T-helper1 (Th1) cells, T-helper17 (Th17) cells and a novel effector T helper cell subpopulation with particular specificity for HAM/TSP called T<sub>HAM</sub>s. The development of novel therapeutic strategies targeting these cells paves the way for new therapeutic strategies, which hold significant promise for providing more favorable treatment outcomes for involved individuals and ameliorating patients' symptoms.

Expert Review of Clinical ImmunologyVol. 21(10)
Golestan University (IR), Jahrom University of Medical Sciences (IR), Golestan University of Medical Sciences (IR), Alborz University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Openalex Percentile: Top 22%
T-cell and Retrovirus Studies
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.